Entacapone acid

CAS No. 160391-70-8

Entacapone acid( —— )

Catalog No. M27764 CAS No. 160391-70-8

Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase(COMT).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 32 In Stock
5MG 28 In Stock
10MG 40 In Stock
25MG 65 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Entacapone acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase(COMT).
  • Description
    Entacapone is a selective and reversible inhibitor of catechol-O-methyltransferase(COMT).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Transferase
  • Recptor
    Filovirus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    160391-70-8
  • Formula Weight
    250.166
  • Molecular Formula
    C10H6N2O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)C(=C\c1cc(O)c(O)c(c1)[N+]([O-])=O)\C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Irina N Gaisina, et al. Discovery and Structural Optimization of 4-(Aminomethyl)benzamides as Potent Entry Inhibitors of Ebola and Marburg Virus Infections. J Med Chem. 2020 Jul 9;63(13):7211-7225.
molnova catalog
related products
  • Ibiglustat (L-Malic ...

    Ibiglustat (L-Malic acid) is a selective, brain-penetrant, and allosteric inhibitor of glucosylceramide synthase.

  • GGTI-2133

    GGTI-2133 is a potent mimetic peptidyl geranylgeranyltransferase type I inhibitor (GGTase I) with an IC50 value of 38 nM.GGTI-2133 inhibits the invasion of inflammatory cells into the airways in experimental asthma in mice.

  • Entacapone

    Entacapone is a selective, reversible catechol-O-methyl transferase (COMT) inhibitor for the treatment of Parkinson's disease.